Molecular medicine infrastructurefor the world's biological intelligence.
NomosLogic has built the deterministic execution layer that transforms genomic data into interaction-aware, ancestry-conditioned, cryptographically anchored clinical intelligence, and a governed discovery layer that generates cross-domain scientific findings no individual researcher would reach.
Where competitors deliver probability, NomosLogic delivers reproducible truth. Same input, same output, every run.
23.8M+
Anchored Molecular Reference Assets
1.76M+
Structured Clinical Logic Objects
497K+
Hardy Bridge Variant Mappings
>190
Cross-Domain Scientific Agents
14
Patent Pillars · WSGR Counsel
7
Downstream Verticals in Production
Investment Thesis
The data generation problem is solved. The informatics question is open.
Sequencing is cheap. Interpretation is not. Clinical laboratories, health systems, payers, pharmaceutical companies, and national genome programs all need the same thing: molecular intelligence infrastructure that is fast, deterministic, continuously updated, ancestry-aware, and built to survive the regulatory environments where genomic data is now used to make real clinical decisions.
Building and maintaining that infrastructure stack is not the sequencing platform's core business. It is ours.
NomosLogic has published the science, filed the IP, and deployed the platform in production. The moat is coherent integration across biology, systems architecture, and regulated workflow. Hard to originate, expensive to recreate.
Where the Substrate Runs
One infrastructure layer. Seven downstream verticals.
The logic layer does not fork. Every vertical runs on the same deterministic substrate.
Clinical genomics
Pharma research
Payer infrastructure
Pharmacogenomics
Research infrastructure
Consumer genomics
Population health
Defensibility
A moat that cannot be bought off the shelf.
14 patent pillars
Filed patent portfolio covering nomenclature resolution, deterministic clinical logic, multi-omic fusion, disease modeling, and visualization layers. IP and corporate counsel: Wilson Sonsini Goodrich & Rosati.
Hardy Bridge
Proprietary nomenclature translation layer resolving variant identity, evidence systems, and clinical vocabularies across rsID, HGVS, star alleles, LOINC, PharmGKB, RxNorm, ICD-10, ClinVar, CPIC, and PubMed.
Deterministic by construction
Same input, same output. Across every run, every system, every jurisdiction. Every clinical assertion is anchored to the exact rule version that produced it. SHA-3-512 provenance on every analytical step, SHA-256 at rest. Built for FDA 510(k), IND, and BLA evidentiary standards.
Governed discovery layer
A network of >190 cross-domain scientific agents operating in a governed commons. Every shared finding clears a deterministic verifier before entering shared knowledge, with tamper-evident provenance on every output and generative lineage recorded per finding.
Traction
The market is every drug that fails unnecessarily.
The majority of Phase II candidates fail for lack of efficacy, often against biological complexity that fragment-centered analysis cannot detect. NomosLogic is the execution layer that closes that gap: for genomic medicine, for drug discovery, and for the patients waiting on both.
- PROTEUS applied to neoantigen target-selection in an active therapeutics collaboration.
- Executive-level conversations underway across consumer genomics.
- Production infrastructure serving clinical, pharma, payer, PGx, research, consumer, and population health verticals from one governed substrate.
Built for global deployment.
Ancestry-conditioned interpretation across every population, sovereign on-premises or in-region cloud deployment, and product surfaces localized into 17 languages. Regional deployment coverage across North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Ready to talk?
For due diligence materials, financials, or a warm intro, use the form below. Choose "Investor" for our investor team, or "Investor (direct to founder)" to route the message straight to Matt Hardy.
Request a Demo
Not looking to invest? Partners and demo requests